Decent Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.74 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.80 M
- Revenue Growth -18.62%
- Profit Growth 113.67%
- Ebitda 52.16%
- Net Worth 0.57%
- Total Assets -8.20%
About Decent Drugs
Decent Drugs Private Limited (DDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 July 2008 and has a history of 16 years and seven months. Its registered office is in Yamuna Nagar, Haryana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.74 M.
The company currently has active open charges totaling ₹8.80 M.
Darshan Bansal and Ekta Bansal serve as directors at the Company.
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233HR2008PTC038155
- Company No.
038155
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2008
- Date of AGM
12 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Decent Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshan Bansal  | Director | 11-Jul-2008 | Current |
| Ekta Bansal | Director | 08-Mar-2013 | Current |
Financial Performance of Decent Drugs.
Decent Drugs Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 18.62% decrease. The company also saw a substantial improvement in profitability, with a 113.67% increase in profit. The company's net worth moved up by a moderate rise of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Decent Drugs?
In 2019, Decent Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.88 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Patiala Sme Branch : 0.88 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2009 | State Bank Of Patiala Sme Branch | ₹8.80 M | Open |
How Many Employees Work at Decent Drugs?
Unlock and access historical data on people associated with Decent Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Decent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Decent Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
